ABOUT US
Vision
Team
History
Contact Us
UNMET NEEDS
Spinal Cord Injury
TECHNOLOGY
Technology
Spinal Cord Injury
Therapeutics
Next-Generation
Stem Cell Therapy
3D Tissue Assembloid
PIPELINE
PUBLICATION/IP
Publication
IP
NEWS & MEDIA
News & Media
Notice
세포 제작 서비스
ABOUT US
Vision
Team
History
Contact Us
UNMET NEEDS
Spinal Cord injury
TECHNOLOGY
Technology
Spinal Cord Injury Therapeutics
Next-Generation Stem Cell Therapy
3D Tissue Assembloid
PIPELINE
PUBLICATION/IP
Publication
IP
NEWS & MEDIA
News & Media
Notice
세포 제작 서비스
H
i
s
t
o
r
y
Abouts Us
About Us
Unmet Needs
Technology
Pipeline
Publication/IP
News & Media
세포 제작 서비스
H
i
s
t
o
r
y
Vision
Team
History
Contact Us
2023
09
SSCA101-related MOU execution with KTR(Korea Testing & Research Institute)
04
SGS101 Patent granted in EU
2022
12
Ministry of SMEs and Startup ‘Commendation from minister‘, Dr. Jeong Beom Kim (CEO)
10
SGS101 Patent granted in China, India
08
MOU execution with Max Planck Institute for Molecular Biomedicine and Ruhr-University Bochum
01
Korean society for stem cell research ‘young scientist award’, Dr. Hyuanh Lee (R&D director)
01
SuPine Therapeutics Seoul office establishment
2021
10
SGD101 Successful clinical application in veterinary treatment (4 cases) (Ulsan S animal medical center collaboration)
2020
12
SSC101 Paper published in Biomaterials (Convergence technology of iHep and ECM hydrogel)
10
SGS101 Patent applied and granted in S.Korea
08
SGS101 Patent granted in Japan
02
SGS101 Patent applied in S.Korea, Patent granted in Australia
2019
10
SGS101 Patent granted in S.Korea
05
Swiss + Korea Global Biotech Startup Network shop- Selected for Top 3 Promising Startup
2018
12
Venture company certified
07
Company auxiliary research institute certified from KOITA
05
Hyundai Heavy Industry technology contest excellence award
03
SGS101 International Patents applied (PCT and 7 countries)
02
Presentation to 19th president of Korea (Jae-In Moon)
2017
11
SuPine Therapeutics Established